• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Mallinckrodt Pharmaceuticals

UPDATED: Mallinckrodt, Marathon leave industry trade group over drug pricing controversy

April 21, 2017 By Sarah Faulkner

Prescription drugs

Updated to include a statement from Mallinckrodt regarding its membership with PhRMA.  Marathon Pharmaceuticals reportedly withdrew from the drug industry’s lobbying group yesterday following controversy over its pricey drug, Emflaza. Pharmaceutical Research and Manufacturers of America (PhRMA) began reconsidering its membership criteria as reports revealed a number of drugmakers hiking the prices of their products. […]

Filed Under: Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Mallinckrodt Pharmaceuticals, Marathon Pharmaceuticals, PTC therapeutics

Mesoblast gains on A$29m investment deal with Mallinckrodt

December 23, 2016 By Sarah Faulkner

Mesoblast gains on A$29m investment deal with Mallinckrodt

Shares in stem cell company Mesoblast Ltd (ASX:MSB) rose 7% to A$1.51 yesterday after it said that it entered into an equity purchase agreement with US drugmaker Mallinckrodt Pharmaceuticals (NYSE:MNK). Mallinckrodt will buy 20.04 million, or nearly 5%, of Mesoblast’s ordinary shares for A$1.48 apiece. According to the agreement, Mallinckrodt will have 9 months to […]

Filed Under: Featured, Funding Roundup, Stem Cells, Wall Street Beat Tagged With: Mallinckrodt Pharmaceuticals, Mesoblast Ltd.

Mallinckrodt touts data for Ofirmev injected acetaminophen

November 18, 2016 By Sarah Faulkner

Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals (NYSE:MNK) today released results from a clinical pharmacokinetic study evaluating the effect of IV morphine on the absorption of oral acetaminophen, touting the effectiveness of its Ofirmev IV administered acetaminophen over orally administered acetaminophen in adjunct to IV morphine. The results were presented at this year’s Pain Medicine Meeting of the American Society of […]

Filed Under: Clinical Trials, Featured, Pain Management, Pharmaceuticals, Surgical Tagged With: Mallinckrodt Pharmaceuticals

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS